03:37 PM EST - Lorus Therapeutics Inc. : announced that the Canadian Patent Office has issued Lorus' patent for its lead small molecule anticancer drug LOR-253. The patent provides Lorus with exclusive rights to LOR-253 in Canada until 2026. Lorus Therapeutics Inc.
shares T.LOR are trading up $0.055 at $0.23.
